Abstract:Background: COVID-19 variants threaten health globally. Despite improving vaccines and treatments, there is an urgent need for alternative strategies to prevent or reduce the severity of COVID-19. Potential strategies include probiotics, which are safe, inexpensive, globally available and have been studied previously in relation to respiratory infections. Methods: We performed a systematic review and meta-analyses of experimental, trial or observational research evidence evaluating probiotics compared with control groups for preventing or treating COVID-19. We searched PubMed, ProQuest, Google Scholar and Web of Science bibliographic databases for studies published until December 6, 2021. We then performed meta-analyses for outcomes reported consistently across studies. Outcomes reported inconsistently or not amenable to meta-analysis were compared descriptively. Results: We identified six eligible studies, which were all published in 2020 and 2021: one randomized controlled trial and five retrospective cohort studies. The only randomized controlled trial reported that groups that ingested probiotics compared with control groups that did not ingest probiotics did not differ significantly with respect to death, severe disease requiring admission to an intensive care unit or disease progression (all p>0.5). The five retrospective cohort studies reported various apparently beneficial and harmful COVID-19 outcome associations with probiotic ingestion. Meta-analyses revealed no significant associations between probiotic use and death, severe disease, or disease progression caused by COVID-19. Descriptive data revealed that probiotic ingestion was associated with a trend towards worsened duration of hospital stay, improvements in measures of respiratory condition and worsened disease duration. The evidence for these contradictory associations was weak because all studies were prone to bias and none were considered to be of high quality. Conclusions: Current evidence does not suggest that probiotics affect COVID-19 severity or mortality. However, additional higher quality studies need to be conducted to definitively determine if probiotics would be a useful adjunctive treatment for COVID-19.

Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?

The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19

Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review

Review Article: Probiotics, Prebiotics and Dietary Approaches During COVID-19 Pandemic

IMPORTANCE OF PROBIOTICS IN THE PREVENTION AND TREATMENT OF COVID-19

Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19

Role of gut microbiota in SARS-CoV-2 infection and the beneficial effects of probiotics on the management of the disease

Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis

Modulated Gut Microbiota for Potential COVID-19 Prevention and Treatment

Can Probiotics and Diet Promote Beneficial Immune Modulation and Purine Control in Coronavirus Infection?

Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection

Probiotics in Prevention and Treatment of COVID-19: Current Perspective and Future Prospects

Probiotics for the prevention and treatment of COVID-19: a rapid systematic review and meta-analysis

Diet, Probiotics and Their Impact on the Gut Microbiota during the COVID-19 Pandemic

Probiotics and Covid-19

The Influence of Probiotic Lactobacilli on COVID-19 and the Microbiota

Probiotics potentials in mitigating coronavirus disease (COVID-19) pandemic

Potential Roles for Probiotics in the Treatment of COVID-19 Patients and Prevention of Complications Associated with Increased Antibiotic Use

Probiotics for preventing or treating COVID-19; a systematic review of research evidence and meta-analyses of efficacy for preventing death, severe disease, or disease progression

Gut microbiota and synbiotic foods: Unveiling the relationship in COVID‐19 perspective

Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: a systematic review and meta-analysis